Difference between revisions of "UK London Anastasiou D"
From Bioblast
Line 1: | Line 1: | ||
<nowiki>{{ | <nowiki>{{O2k-Network Lab | ||
|address=[[Anastasiou D|Anastasiou Dimitrios]], | |address=[[Anastasiou D|Anastasiou Dimitrios]], | ||
Line 11: | Line 11: | ||
|city=London | |city=London | ||
|country=United Kingdom | |country=United Kingdom | ||
|Contact=Anastasiou D | |||
|MiPNetLab=Anastasiou D, Williams M | |||
|Team previous= | |||
|Status= | |||
|info= | |||
|weblink= | |weblink= | ||
}} | }} |
Revision as of 17:06, 5 March 2015
UK London Anastasiou D
O2k-Network Lab | |
---|---|
Address | Anastasiou Dimitrios,
Developmental Biology / Physiology and Metabolism / Stem Cell Biology and Developmental Genetics / Systems Biology MRC National Institute for Medical Research The Ridgeway Mill Hill London NW7 1AA, United Kingdom, |
City | London |
State/Prov | |
Country | United Kingdom |
Weblink | |
Contact | Anastasiou D |
Team | Anastasiou D, Williams M |
Team previous | |
Status | |
Oroboros Events | |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Fets 2022 Commun Biol | 2022 | Fets L, Bevan N, Nunes PM, Campos S, Dos Santos MS, Sherriff E, MacRae JI, House D, Anastasiou D (2022) MOG analogues to explore the MCT2 pharmacophore, Ξ±-ketoglutarate biology and cellular effects of N-oxalylglycine. https://doi.org/10.1038/s42003-022-03805-y |
Fets 2018 Nat Chem Biol | 2018 | Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Silva Dos Santos M, MacRae JI, O'Reilly N, Wright AJ, Benes CH, Courtney KD, House D, Anastasiou D (2018) MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nat Chem Biol 14:1032-42. |
O2k-Abstracts
update please